Skip to content
Company Analysis

Alvotech ALVO

A comprehensive view of key metrics, scores, and financial health for Alvotech

Overview of Alvotech

ALVO NGM
Healthcare Drug Manufacturers - Specialty & Generic Framework: Pharma / Mature Biotech Small Cap
Alvotech (ALVO), is a Small Cap company, in the Drug Manufacturers - Specialty & Generic industry, last closed at $4.48, about 3.3% overvalued vs fair value, -11.5% 1Y return, ranked 779/1145 in sector.
Metrics P/E 51.3× Rev Growth 19.7% ROE -8.0% Gross Margin 59.8%
USD 4.48
-3.66%
(Delayed)
• Vol 90d: 70.6%
52-Week Range
Market Cap
$1.60B
Enterprise Value
$2.76B
Overall Score
View breakdown
Overall
Growth
Weak
Profitability
Fair
Health
Fair
Efficiency
Weak
Valuation
Fair
Growth
Weak
Profitability
Fair
Health
Fair
Efficiency
Weak
Valuation
Fair
Completeness: 88%
Confidence: 92%
Updated: Oct 31
Top Beats

Quick Facts

Website https://www.alvotech.com
HQ Luxembourg
Employees 1,012
Fiscal year Dec 31

Next Events

Earnings Nov 11 Call: Nov 12

Fair Value Snapshot

Bear Base Bull
$4
$4
$5
Current: $4.48 -3% vs base

Engine Room Money Flow™

Small Cap

Pharmaceutical / Mature Biotech - Where revenue goes and how value is created

Flow Steps
Total Revenue
$586.3M
19.7%%
Gross Profit
$350.8M
15.2%%
R&D Expense
$184.2M
7.5%%
Operating Income (EBIT)
$273.2M
529.8%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Pharmaceutical / Mature Biotech

Quality & Reliability Indicators

Cash Conversion
-18.4%
Poor

Weak cash conversion - investigate working capital

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health some concerns
Moderate efficiency issues detected. Review active leaks below for improvement areas.
4
Active Leaks
1/4
Improving
0
High Impact
0
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating Alvotech's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
55
/100
Moderate
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Cost Leadership Position Operating margin at 78.8th percentile with strong OpEx control demonstrates cost leadership.
  • ROIC Sustainably Above Peers ROIC at 70.7th percentile exceeds peers and WACC, demonstrating superior capital allocation.

Key risks

  • Revenue Volatility Signals Weak Stickiness Revenue volatility is high (stability score 0.18), suggesting weak customer stickiness.
  • Weak or Negative Cash Flow Cash generation is weak (score 0.31), limiting financial flexibility.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Developing
47
Premium

Signals, strengths and risks for Pricing Power

Premium

Signals, strengths and risks for Cost Advantage

Premium

Signals, strengths and risks for Customer Stickiness

Premium

Signals, strengths and risks for Capital Efficiency

Premium

Signals, strengths and risks for Resilience

Premium

Signals, strengths and risks for Scale & Market Position

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

vs Industry Peers 84% Coverage
Trade-Off Triangle Visualization A ternary plot showing ALVO's balance between Growth (43.2%), Profitability (31.7%), and Safety (25.1%). Growth 43% Safety 25% Profitability 32%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

86th percentile vs peers
87
Key Signals
Rev Growth YoY 19.7% 81p Revenue CAGR 3Y 91.8% 95p EPS Growth YoY 1.11 83p
Strengths
  • Growth performance in top 20% of peers (percentile: 86)
  • Rev Growth YoY in top 20% of peers (19.7%, 81th percentile)
  • Revenue CAGR 3Y in top 20% of peers (91.8%, 95th percentile)
  • EPS Growth YoY in top 20% of peers (1.11, 83th percentile)
Risks

No significant risks identified for this axis.

Profitability

63th percentile vs peers
63
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

50th percentile vs peers
50
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Alvotech.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$4.33
- - -
-3.3% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000